Transforming growth factor β receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk

MLA

Spillman, Monique A., et al. “Transforming Growth Factor β Receptor I Polyalanine Repeat Polymorphism Does Not Increase Ovarian Cancer Risk.” Gynecologic Oncology, vol. 97, no. 2, May 2005, pp. 543–49. EBSCOhost, https://doi.org/10.1016/j.ygyno.2005.01.025.

APA

Spillman, M. A., Schildkraut, J. M., Halabi, S., Moorman, P., Calingaert, B., Bentley, R. C., Marks, J. R., Murphy, S., & Berchuck, A. (2005). Transforming growth factor β receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk. Gynecologic Oncology, 97(2), 543–549. https://doi.org/10.1016/j.ygyno.2005.01.025

Chicago

Spillman, Monique A., Joellen M. Schildkraut, Susan Halabi, Patricia Moorman, Brian Calingaert, Rex C. Bentley, Jeffrey R. Marks, Susan Murphy, and Andrew Berchuck. 2005. “Transforming Growth Factor β Receptor I Polyalanine Repeat Polymorphism Does Not Increase Ovarian Cancer Risk.” Gynecologic Oncology 97 (2): 543–49. doi:10.1016/j.ygyno.2005.01.025.